Evaluation and management of transient lower urinary tract symptoms (LUTS) after surgery for Benign prostatic obstruction (BPO): a systematic review.

Prostate Cancer Prostatic DisApr 8, 2026 (epub)
Clinical ResearchUrology

Giacomo Gallo, Riccardo Lombardo, Antonio Cicione et al.

✦ AI-curated · Sources linked

In 30 seconds

This systematic review assessed treatments and evaluation methods for transient lower urinary tract symptoms after benign prostatic obstruction surgery in men. It included nine randomized clinical trials, with most evidence relating to transurethral resection of the prostate. Assessment methods and timing varied substantially. Anticholinergic drugs appeared to provide the greatest symptom improvement, but evidence was low; alpha-blockers showed no significant additional benefit. Phytocomplexes improved quality of life, while pelvic floor muscle exercises reduced symptom-related bother. Overall, the review found the evidence limited and current management strategies heterogeneous.

Key findings

  • Nine randomized clinical trials were included; most available data concerned transurethral resection of the prostate.
  • Anticholinergic drugs appeared most effective for postoperative LUTS, although the level of evidence was low.
  • Alpha-blockers did not appear to provide significant additional benefit in this setting.
  • Phytocomplexes improved quality of life, and pelvic floor muscle exercises reduced symptom-related bother.

Why it matters

Transient urinary symptoms after BPO surgery are assessed and managed inconsistently, and the available trial evidence does not establish a robust approach. The review helps distinguish interventions with some reported benefit from those without apparent additional benefit, while underscoring that these findings are not strong enough to support firm recommendations.

What to keep in mind

Only nine RCTs were included, assessment methods and timing varied considerably, and the evidence for anticholinergic efficacy was low.

Source

Published in Prostate Cancer Prostatic Dis. This summary was written by xxcode from the publication's abstract and metadata. It is not peer reviewed and is not a substitute for the original article. For clinical decisions, review the original publication.

ShareTelegramLinkedIn

AI-generated summaries may contain errors or omissions. Verify clinically important information with the original publication.

More in Urology

Want this personalized?

Stop searching the literature. Choose what you follow and xxcode will build your personalized medical digest.

  • Your specialties
  • Your filters and thresholds
  • Clinical Research + Case Reports, tuned separately
  • Automatic weekly delivery
  • Audio and text

Prefer listening? Personalized audio digests are available with Pro.

Stay updated for free

Get the 3 most interesting publications in one specialty each week.

Weekly email. Unsubscribe anytime.